Clinical trial
Organ Motion and Early Tumor Response Measurement During Chemotherapy for Esophageal Cancer
NCT02139488 is registered in ClinicalTrials.gov with The Netherlands Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Organ Motion and Early Tumor Response Measurement During Chemotherapy for Esophageal Cancer
- Lead sponsor
- The Netherlands Cancer Institute
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 18, 2014
- Completion date
- December 31, 2018
- Enrollment
- 80 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chemoradiation, esophageal cancer